SN-38 (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "SN-38" in Serbian language version.

refsWebsite

Global rank Serbian rank

5doi.org

2^nd place

4^th place

1sciencedirect.com

149^th place

283^rd place

1nih.gov

4^th place

8^th place

1wikipedia.org

low place

1aacrjournals.org

8,869^th place

8,510^th place

1nature.com

234^th place

287^th place

aacrjournals.org (Global: 8,869^th place; Serbian: 8,510^th place)

cancerres.aacrjournals.org

Fumiaki K, Masayuki K, Takahito N, Takeshi O, Shin-ichi M, Tetsuya H, Yasuhiro M (2006). „Novel SN-38–Incorporating Polymeric Micelles, NK012, Eradicate Vascular Endothelial Growth Factor–Secreting Bulky Tumors”. Cancer Research. 66: 10048. doi:10.1158/0008-5472.CAN-06-1605.

doi.org (Global: 2^nd place; Serbian: 4^th place)

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
Fumiaki K, Masayuki K, Takahito N, Takeshi O, Shin-ichi M, Tetsuya H, Yasuhiro M (2006). „Novel SN-38–Incorporating Polymeric Micelles, NK012, Eradicate Vascular Endothelial Growth Factor–Secreting Bulky Tumors”. Cancer Research. 66: 10048. doi:10.1158/0008-5472.CAN-06-1605.
Mathijssen RH, Verweij J, Loos WJ, Bruijn P, Nooter K, Sparreboom A (202). „Irinotecan pharmacokinetics-pharmacodynamics: the clinical relevance of prolonged exposure to SN-38”. British Journal of Cancer. 87: 144—150. doi:10.1038/sj.bjc.6600447.
Andersson T, Flockhart DA, Goldstein DB (2005). „Drug-metabolizing enzymes: Evidence for clinical utility of pharmacogenomic tests” (PDF). Clin Pharmcol Thera. 78 (6): 559—584. doi:10.1016/j.clpt.2005.08.013.

nature.com (Global: 234^th place; Serbian: 287^th place)

Andersson T, Flockhart DA, Goldstein DB (2005). „Drug-metabolizing enzymes: Evidence for clinical utility of pharmacogenomic tests” (PDF). Clin Pharmcol Thera. 78 (6): 559—584. doi:10.1016/j.clpt.2005.08.013.

nih.gov (Global: 4^th place; Serbian: 8^th place)

ncbi.nlm.nih.gov

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди

sciencedirect.com (Global: 149^th place; Serbian: 283^rd place)

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди

wikipedia.org (Global: low place; Serbian: low place)

sr.wikipedia.org

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди

SN-38 (Serbian Wikipedia)

aacrjournals.org (Global: 8,869th place; Serbian: 8,510th place)

cancerres.aacrjournals.org

doi.org (Global: 2nd place; Serbian: 4th place)

nature.com (Global: 234th place; Serbian: 287th place)

nih.gov (Global: 4th place; Serbian: 8th place)